Recs

7

Today's Big Dow Winners

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

After yesterday's rally to start the fourth quarter, news from Spain spoiled investors' confidence. Spain's prime minister stomped on the rumor that his country was ready to ask for a European Union bailout. The Fool's John Maxfield believes part of the slide can also be contributed to a hedge-fund manager's comments about a number of different companies. Regardless, the Dow Jones Industrial Average (INDEX: ^DJI  ) wiped out most of the gains from yesterday's rally. The index closed at 13,482, down more than 32 points, or 0.2%. But not all was lost, as a number of stocks ended the day up.

And the winners are ...
UnitedHeath Group
(NYSE: UNH  ) saw its shares rise by 0.60% during today's trading session. Very little news could be found pertaining to the company, but one eye-catching health-care-related story involved Washington Post (NYSE: WPO  ) . This story wasn't one you could read about only in the Post; it was that the newspaper company was buying a majority stake in health-care provider Celtic Healthcare. While this addition may seem odd considering Washington Post's current business mix, it does show that outsiders are feeling positive about the future of the health-care industry.

Although Microsoft (Nasdaq: MSFT  ) briefly lost the coveted spot as the second-largest company in the world, Google's market capitalization was briefly higher today, but Mr. Softy ended the day still holding the title. Bill Gates' software company ended the day up 0.58%. This comes a day after Hewlett-Packard unveiled its newest tablet, the HP ElitePad 900, which will run on the Windows 8 operating system.

Another Dow Component trading higher today was Merck (NYSE: MRK  ) . The drug manufacturer finished the day 0.56% higher following a late announcement yesterday that Gardasil, Merck's vaccine to prevent cervical cancer, was shown to be safe from any major side effects. The findings came from the second large-scale study performed on the drug in just the past year.

On Tuesday, it was also announced that Merck had entered into a partnership with Ablynx, a Belgian drug developer. Merck will gain exclusive rights to special nanobodies made by Ablynx scientists, which are one-tenth the size of normal antibodies. The size difference means they could be taken orally, as opposed to previously being injected, and the antibodies may therefore be able to reach new targets in the body.

While these stocks rose today, they may fall tomorrow. Every company is susceptible to market news and macroeconomic events, and a major market-moving event is quickly approaching: the presidential election. A few stocks could skyrocket, depending on who gets elected. To find out which ones before you miss out, click here.

Fool contributor Matt Thalman owns shares of Microsoft. The Motley Fool owns shares of Google and Microsoft. Motley Fool newsletter services have recommended buying shares of Google and UnitedHealth Group, creating a synthetic covered call position in Microsoft, and creating a diagonal call position in UnitedHealth Group. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2041207, ~/Articles/ArticleHandler.aspx, 8/1/2015 2:02:46 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Matt Thalman
TMFMT

Matt primarily covers the Dow Components, the Major Indexes daily moves, Consumer Goods stocks, and General Investing Topics.

Today's Market

updated 4 hours ago Sponsored by:
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASD 5,128.28 -0.50 -0.01%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/31/2015 4:36 PM
^DJI $17689.86 Down -56.12 -0.32%
DOW JONES INDUSTRI… CAPS Rating: No stars
GHC $689.56 Up +1.10 +0.16%
Graham Holdings CAPS Rating: ***
MRK $58.96 Up +0.44 +0.75%
Merck & Co., Inc. CAPS Rating: ****
MSFT $46.70 Down -0.18 -0.38%
Microsoft CAPS Rating: ***
UNH $121.40 Up +0.84 +0.70%
UnitedHealth Group CAPS Rating: *****

Advertisement